Current status of robot-assisted total pelvic exenteration focusing on the field of urology: a clinical practice review

Jun Kamei,Tetsuya Fujimura

DOI: https://doi.org/10.21037/tcr-23-1039

2024-02-02

Translational Cancer Research

Abstract:Keywords: Cystectomy; pelvic exenteration (PE); prostatectomy; robotic surgery

oncology

What problem does this paper attempt to address?

Robotic versus open and laparoscopic pelvic exenterations for pelvic cancer: a multicenter propensity-matched analysis in Japan

Yusuke Yatabe,Marie Hanaoka,Ryoichi Hanazawa,Akihiro Hirakawa,Toshiki Mukai,Kei Kimura,Koji Yamanoi,Jin Kono,Mitsuru Yokota,Hiroki Takahashi,Akihiro Kobayashi,Kenji Kobayashi,Nobuki Ichikawa,Masayoshi Yasui,Keita Nakane,Manabu Yamamoto,Atsushi Takenaka,Yuya Nakamura,Ichiro Takemasa,Norimitsu Yabusaki,Shintaro Akamoto,Shuichi Tatarano,Kohei Murata,Tatsuya Manabe,Tetsuya Fujimura,Mikio Kawamura,Hiroyuki Egi,Shigeki Yamaguchi,Yoshito Terai,Shigetaka Inoue,Akihiro Ito,Yusuke Kinugasa

DOI: https://doi.org/10.1007/s00464-024-10966-w

2024-06-19

Surgical Endoscopy

Abstract:Pelvic exenteration (PE) is the last resort for achieving a complete cure for pelvic cancer; however, it is burdensome for patients. Minimally invasive surgeries, including robot-assisted surgery, have been widely used to treat malignant tumors and have also recently been used in PE. This study aimed to evaluate the safety and efficacy of robot-assisted PE (RPE) by comparing the outcomes of open PE (OPE) with those of conventional laparoscopic PE (LPE) for treating pelvic tumors.

surgery
Robotic Partial Nephrectomy: Current Technique and Outcomes

Liang Wang,Benjamin R Lee

DOI: https://doi.org/10.1111/iju.12177

2013-01-01

International Journal of Urology

Abstract:AbstractOver the past decade, management of the T1 renal mass has focused on nephron‐sparing surgery. Robotic partial nephrectomy has played an increasing role in the technique of preserving renal function by decreasing warm ischemia time, as well as optimizing outcomes of hemorrhage and fistula. Robot‐assisted partial nephrectomy is designed to provide a minimally‐invasive nephron‐sparing surgical option utilizing reconstructive capability, decreasing intracorporeal suturing time, technical feasibility and safety. Ultimately, its benefits are resulting in its dissemination across institutions. Articulated instrumentation and three‐dimensional vision facilitate resection, collecting system reconstruction and renorrhaphy, leading to decreased warm ischemia time while preserving oncological outcomes. The aim of the present review was to present our surgical sequence and technique, as well as review the current status of robot‐assisted partial nephrectomy.
Current status and future perspective of robot‐assisted radical cystectomy for invasive bladder cancer

Tetsuya Fujimura

DOI: https://doi.org/10.1111/iju.14076

2019-07-30

International Journal of Urology

Abstract:<p>The current status of robot‐assisted radical cystectomy was reviewed 16 years after the initial robot‐assisted radical cystectomy for the treatment of invasive bladder cancer. Articles associated with robot‐assisted radical cystectomy and written in English were selected from the PubMed database from January 2003 to February 2019. The present review article focused on the distribution of robot‐assisted radical cystectomy, patient selection, preoperative management, surgical technique, lymph node dissection, urinary diversion, recurrence pattern, oncological outcomes, cost, learning curve, complications and educational programs. A total of 400 articles were divided according to the country of the first author's affiliation. The USA was the most dominant at 198 (50%), whereas the number of articles from the countries belonging to the Urological Association of Asia was 15 (3.8%) for China, 17 (4.3%) for South Korea, 10 (2.5%) for Japan, eight (2%) for Taiwan, eight (2%) for Turkey and one (0.2%) for Iran. The percentage of robot‐assisted radical cystectomy carried out is increasing, and intracorporeal urinary diversion and ileal neobladder are also frequently carried out. With a refined technique being performed in high‐volume centers, robot‐assisted radical cystectomy has contributed to the reduction in transfusion rate, length of stay and severe complications; however, it has not yet shown any cancer‐specific survival benefits. Robot‐assisted radical cystectomy is not fully spread throughout the Urological Association of Asia. Further investigation with respect to worldwide results is needed to prove the real benefit of robot‐assisted radical cystectomy regarding low morbidity, reduced total medical cost, and survival benefit. In the era of precision medicine, appropriate drug and surgery will be given based on each genetic profile.</p>

urology & nephrology
Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus after Robot-Assisted Laparoscopic Radical Cystectomy

Shuai Wang,Dahong Zhang,Yuchen Bai,Feng Liu,Xiaolong Qi,Liping Xie

DOI: https://doi.org/10.1089/lap.2023.0118

2023-01-01

Abstract:Objective: The purpose of this study was to compare the clinical outcomes of bladder cancer patients treated with extended pelvic lymph node dissection (ePLND) before or after cystectomy under robotic-assisted radical cystectomy (RARC).Methods: A retrospective study to identify 348 patients with bladder cancer who underwent RARC was performed. Of the patients, 152 (42.8%) underwent ePLND before radical cystectomy (RC) (group A) and 196 (56.3%) underwent ePLND after RC (group B). The clinical, pathological, and overall survival were compared.Results: The total and RC operation time in Group A (total: 130.68 +/- 29.25 minutes, RC: 59.45 +/- 28.63 minutes) were both shorter than Group B (total: 154.17 +/- 38.18 minutes, RC: 94.81 +/- 41.21 minutes) (P < .05). However, no significant difference in time of ePLND. The estimate blood loss (EBL) of RC part and total operation (RC+ePLND) in group A was less than group B (both P < .05), while the ePLND part did not show significance. The result of vascular and nerve injury and surgical drain withdrawal time were similar in two groups. The total number of lymph nodes in group A was fewer than group B (16 versus 26; P < .05). Moreover, the number of bilateral internal iliac and presacral lymph nodes of group A was fewer than group B significantly, whereas the number of bilateral external iliac, common iliac, and obturator lymph nodes was similar in two groups. The lymph node density of group A was significantly lower than group B. The median follow-up of all patients was 33.0 months. Importantly, the survival of group B was better than group A (hazard ratio: 1.412; 95% confidence interval: 1.004-1.987; P = .048).Conclusions: Performing ePLND before RC reveals better result on operation time and EBL, while, when ePLND after RC, the total number of lymph nodes dissected is more and the survival is better. It recommended ePLND be performed before RC, and it is necessary to recheck the internal iliac and presacral area after cystectomy.
Current Status of Robotics in Urologic Laparoscopy

Matthew T Gettman,Michael L Blute,Reinhard Peschel,Georg Bartsch

DOI: https://doi.org/10.1016/s0302-2838(02)00579-1

IF: 24.267

2003-02-01

European Urology

Abstract:Urology has continuously embraced novel technologies like laparoscopy that reduce patient morbidity yet maintain an excellent standard of care. Because of limitations on maneuverability, operative vision, manual dexterity, and tactile sense, laparoscopy can be more difficult to perform than corresponding tasks in open surgery. To potentially increase clinical applicability of laparoscopy, robots that enhance operative performance have recently been introduced for a variety of laparoscopic procedures such as laparoscopic radical prostatectomy, pyeloplasty, and even laparoscopic cystectomy and neobladder construction. While these robots have generated excitement and many robotic applications have been described, the benefit of the advanced technology in expanded series of patients remains largely unknown. In addition, the ability of telerobotics to be used by surgeons inexperienced in conventional laparoscopy is also poorly understood. This review compares current features of available robots, advantages and limitations of robots, the emerging clinical applications, and the future potential of robotics in urology.

urology & nephrology
Robotic-assisted laparoscopic surgery: recent advances in urology

Riccardo Autorino,Homayoun Zargar,Jihad H Kaouk

DOI: https://doi.org/10.1016/j.fertnstert.2014.05.033

Abstract:The aim of the present review is to summarize recent developments in the field of urologic robotic surgery. A nonsystematic literature review was performed to retrieve publications related to robotic surgery in urology and evidence-based critical analysis was conducted by focusing on the literature of the past 5 years. The use of the da Vinci Surgical System, a robotic surgical system, has been implemented for the entire spectrum of extirpative and reconstructive laparoscopic kidney procedures. The robotic approach can be applied for a range of adrenal indications as well as for ureteral diseases, including benign and malignant conditions affecting the proximal, mid, and distal ureter. Current evidence suggests that robotic prostatectomy is associated with less blood loss compared with the open surgery. Besides prostate cancer, robotics has been used for simple prostatectomy in patients with symptomatic benign prostatic hyperplasia. Recent studies suggest that minimally invasive radical cystectomy provides encouraging oncologic outcomes mirroring those reported for open surgery. In recent years, the evolution of robotic surgery has enabled urologic surgeons to perform urinary diversions intracorporeally. Robotic vasectomy reversal and several other robotic andrological applications are being explored. In summary, robotic-assisted surgery is an emerging and safe technology for most urologic operations. The acceptance of robotic prostatectomy during the past decade has paved the way for urologists to explore the entire spectrum of extirpative and reconstructive urologic procedures. Cost remains a significant issue that could be solved by wider dissemination of the technology.
Robot-assisted radical cystectomy for bladder cancer after low anterior resection: A case report

Shoutarou Watanabe,Hiroaki Kobayashi,Nao Hiroe,Tomohiro Iwasawa,Michio Kosugi,Masayuki Shimizu,Masaru Ishida

DOI: https://doi.org/10.1111/ases.13345

Abstract:Radical cystectomy after low anterior resection is rare, and no cases of robotic surgery have been reported. Cystectomy in patients who have undergone a previous pelvic surgery, whether open or endoscopic, requires caution to avoid damaging other organs due to anatomical changes caused by adhesions in a limited space. Additionally, the curative nature of the treatment must be maintained. We describe a 69-year-old man with a history of open low anterior resection for rectal cancer who underwent robot-assisted radical cystectomy with extracorporeal ileal conduit construction. Although this procedure is challenging, it was performed safely with the collaboration of colorectal surgeons. The patient was discharged without perioperative complications and remained recurrence-free for 5 years.
The current state and the future of robotic surgery in female pelvic medicine and reconstructive surgery.

R. Sussman,B. Brucker,B. Peyronnet

DOI: https://doi.org/10.5152/tud.2019.19068

2019-09-01

Abstract:In this article, we review the current uses and future directions of robotic surgery in the field of female pelvic medicine and reconstructive surgery. Pelvic surgery is ideal for the use of surgical robots, which provide improved visualization and ease of suturing deep within the pelvis. Robots have been successfully used for the treatment of pelvic organ prolapse, in procedures such as sacrocolpopexy, sacrohysteropexy, and uterosacral ligament plication. Surgeons have used the robotic successfully to treat various etiologies of female pelvic pain including fibroids, endometriosis, and nerve entrapment. Robotic repair of iatrogenic injury has been described with excellent outcomes and avoidance of conversion to open surgery in the event of an injury caused using the robotic platform. While more data is needed on this topic, there has been increasing interest in using the robot for urologic reconstruction including repair of vesico-vaginal fistula, cystectomy, augmentation cystoplasty, and continent and non-continent diversions. Recently the use of the robot has been described in the treatment of stress urinary incontinence in females, with robotic placement of an artificial urinary sphincter. While robotic surgery is associated with increased cost, the outcomes of robotic surgery in female urology are promising. More studies that properly evaluate the benefits of robotic surgery as compared to open and laparoscopic approaches are needed.

Medicine,Engineering
Robot-Assisted Surgery for Endometriosis Current and Future Perspectives

Emad Mikhail,Zoran Jason Pavlovic,Maha Al Jumaily,Mira H Kheil,Gaby N Moawad,Thiers Soares

DOI: https://doi.org/10.52198/22.STI.40.GY1562

2022-05-19

Abstract:Successful resection of all visible lesions may effectively treat endometriosis-related infertility and pelvic pain. Minimally invasive surgery provides significant advantages, with lower rates of surgical complications such as surgical trauma, infection, postoperative pain, and hospital stay. Robotic surgery is shown to have similar perioperative outcomes to conventional laparoscopy; however, complex stage III and IV endometriosis, especially cases requiring significant resection such as deep infiltrating endometriosis, widespread peritoneal implants, and urologic and intestinal involvement, may benefit most from a robotic approach. There are certain aspects of endometriosis surgery where utilization of robotic technology might provide an additional benefit. These include (1) heterogeneity of lesions, and thus difficulty in identification; (2) difficulty in accurately predicting surgical complexity; and (3) prolonged operative time for complex cases. The objective of this review is to describe the current and future perspectives of robotic surgery as it pertains to endometriosis.
AB099. Pelvic Exenteration for Primary and Recurrent Malignancies in Urology Department

Zhijun Xi,Bing Wang,Zhengfei Zhou

DOI: https://doi.org/10.3978/j.issn.2223-4683.2015.s099

2015-01-01

Translational Andrology and Urology

Abstract:Objective For locally advanced and recurrent pelvic malignancies, radical margins are sometimes difficult to obtain because of close relation to or growth in adjacent organs/structures. Pelvic exenteration (PE) could be an extensive operation for these advanced tumors and involves en bloc resection of the bladder, and internal genital organs (prostate/seminal vesicles or uterus, ovaries and/or vagina) or sometimes rectum (TPE). The objective of present study is to investigate the safety and efficacy of PE for the treatment of pelvic malignancies in urology department.
A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients

DOI: https://doi.org/10.1186/s12885-024-12377-5

IF: 4.638

2024-05-16

BMC Cancer

Abstract:Total pelvic exenteration (TPE), an en bloc resection is an ultraradical operation for malignancies, and refers to the removal of organs inside the pelvis, including female reproductive organs, lower urological organs and involved parts of the digestive system. The aim of this meta-analysis is to estimate the intra-operative mortality, in-hospital mortality, 30- and 90-day mortality rate and overall mortality rate (MR) following TPE in colorectal, gynecological, urological, and miscellaneous cancers.

oncology
Minimally invasive pelvic exenteration for primary or recurrent locally advanced rectal cancer: A glimpse into the future

Dimitrios Kehagias,Charalampos Lampropoulos,Ioannis Kehagias

DOI: https://doi.org/10.4240/wjgs.v16.i7.1960

2024-07-27

World J Gastrointest Surg

Abstract:Surgeons have grappled with the treatment of recurrent and T4b locally advanced rectal cancer (LARC) for many years. Their main objectives are to increase the overall survival and quality of life of the patients and to mitigate postoperative complications. Currently, pelvic exenteration (PE) with or without neoadjuvant treatment is a curative treatment when negative resection margins are achieved. The traditional open approach has been favored by many surgeons. However, the technological advancements in minimally invasive surgery have radically changed the surgical options. Recent studies have demonstrated promising results in postoperative complications and oncological outcomes after robotic or laparoscopic PE. A recent retrospective study entitled "Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review" was published in the World Journal of Gastrointestinal Surgery. As we read this article with great interest, we decided to delve into the latest data regarding the benefits and risks of minimally invasive PE for LARC. Currently, the small number of suitable patients, limited surgeon experience, and steep learning curve are hindering the establishment of minimally invasive PE.
Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia

Stefano Puliatti,Stefania Ferretti,Natali Rodriguez Peñaranda,Ahmed Eissa,Marco Ticonosco,Andrea De Faveri,Cosimo De Carne,Pawel Wisz,Riccardo Ferrari,Greta Tosi,Filippo Annino,Giampaolo Bianchi,Salvatore Micali

DOI: https://doi.org/10.1590/S1677-5538.IBJU.2023.0608

Abstract:Background: The ectopic pelvic kidney, a common renal anomaly, is often smaller and malformed, with a shorter and sometimes tortuous ureter (1). Muscle-invasive bladder cancer (MIBC), constituting 15-25% of bladder cancer cases (2), mandates radical cystectomy with a 50% 5-year survival rate (2). Despite the growing use of robot-assisted radical cystectomy (RARC) (3, 4), there is limited data on its application in ectopic kidneys. Only one RARC case has been reported (5), in contrast to numerous open radical cystectomies (1, 6) involving an ectopic kidney. Patient and methods: After being diagnosed with T2 high-grade urothelial carcinoma, the 66-year-old patient, previously treated with multiple transurethral resections and adjuvant BCG therapy, received neoadjuvant chemotherapy. Preoperative staging CT revealed a 2.6 x 2.2 cm bladder neoformation and an ectopic right pelvic kidney. Results: Using the da Vinci Surgical System, radical cystectomy with ileal conduit (sec Wallace II) and lymphadenectomy were performed. During the demolition phase, the shorter right ureter was dissected with care to avoid damage to the renal pedicle. The reconstructive phase included intracorporeal urinary diversion (ICUD) and uretero-ileal anastomosis, facilitated by the favorable position of the kidney. The 8-hour console surgery resulted in minimal blood loss. Discharged on day 16 due to COVID-19, the patient exhibited positive outcomes. A 2-month CT follow-up revealed no cancer recurrence, metastasis, hydronephrosis, and complete regression of the lymphocele. Imaging follow-up continues without postoperative adjuvant chemotherapy. Conclusion: Robotic surgery with intracorporeal urinary diversion holds potential for right-sided pelvic kidney cases, but additional studies are necessary for validation.
Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis

Reuben Ben-David,Francesco Pellegrino,Parissa Alerasool,Neeraja Tillu,Etienne Lavallee,Kyrollis Attalla,Nikhil Waingankar,Sfakianos P. John,Reza Mehrazin,Marco Moschini,Alberto Martini,Sebastian Edeling,Alberto Briganti,Francesco Montorsi,Peter Wiklund

DOI: https://doi.org/10.1007/s00345-024-04942-1

2024-04-25

World Journal of Urology

Abstract:Robotic-assisted radical cystectomy (RARC) offers decreased blood loss during surgery, shorter hospital length of stay, and lower risk for thromboembolic events without hindering oncological outcomes. Cutaneous ureterostomies (UCS) are a seldom utilized diversion that can be a suitable alternative for a selected group of patients with competing co-morbidities and limited life expectancy.

urology & nephrology
Robotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic review

Afra Zahid,Muhammad Ayyan,Minaam Farooq,Huzaifa Ahmad Cheema,Abia Shahid,Faiza Naeem,Muhammad Abdullah Ilyas,Shehreen Sohail

DOI: https://doi.org/10.1007/s11701-022-01416-7

2022-05-09

Journal of Robotic Surgery

Abstract:To establish the feasibility of robotic surgical procedures in urology in terms of the applications, merits, and demerits as well as the postoperative and oncological outcomes while comparing it with the conventional approaches. A systematic search of electronic databases was performed to identify Randomized Controlled Trials and Cohort studies on Robot-Assisted urological surgical procedures in comparison with the conventional methods. The quality assessment of included studies was performed using the Newcastle–Ottawa Scale and the revised Cochrane "Risk of Bias" tool. A qualitative narrative synthesis of the data extracted from the studies was performed and presented in tabulated form. After screening, 39 studies were included in our review (7 Randomized Controlled Trials and 32 Cohort studies). Robot-Assisted Prostatectomy appears to be associated with lower estimated blood loss and shorter length of hospital stay. For Robot-Assisted Cystectomy, the results suggest longer operative time and fewer complications. Robot-Assisted Radical Nephrectomy was found to be associated with fewer perioperative complications and longer mean operative time while Robot-Assisted Partial Nephrectomy was associated with less positive surgical margins and reduced need for postoperative analgesia. The mean operative time was longer while the length of stay was shorter for the robotic approach in inguinal lymphadenectomy and ureteral reimplantation. The feasibility of Robot-Assisted surgery varied for different outcome measures as well as for different procedures. Some common advantages were a shorter length of stay, lesser blood loss, and fewer complications while the drawbacks included longer operative time. Study protocol PROSPERO database (Registration Number: CRD42021256623).
Current status, evolution, and future perspectives in robotic platform systems for prostate cancer treatment: a narrative review

Flavia Tamborino,Guglielmo Dello Stritto,Gaetano Salzano,Peppino Lannutti,Marco Mascitti,Alessio Digiacomo,Martina Basconi,Rossella Cicchetti,Angelo Orsini,Matteo Ferro,Riccardo De Archangelis,Luigi Schips,Michele Marchioni

DOI: https://doi.org/10.21037/cco-24-47

Abstract:Background and objective: Robotic surgery has contributed greatly to the shift from traditional surgery to minimally invasive surgery. Urology is the major field of application of robotic surgery. Several urological procedures, especially radical prostatectomy, benefit from the use of robotic surgery. Methods: Non-systematic research of the literature was performed using "Robot-assisted radical prostatectomy" and "Robotic platforms" as keywords to understand the actual situation and the future perspectives of this technology in prostate cancer treatment. Key content and findings: The robotic platform landscape is constantly evolving. DaVinci has always been the mainstay in this field, particularly after the advent of the new single port platforms. New platforms are emerging, providing an alternative option to the well-known DaVinci system. Since in literature, few studies compare the use of different robotic platforms, their application in urological procedures is not yet widely used, for both oncological and non-oncological procedures. Furthermore, artificial intelligence begins to play a role in this landscape and could be useful for future developments. So further studies are warranted to give a full comprehension of the whole scenario. Conclusions: This review aims to analyze the current state of the use of robotic platforms in urology, particularly in radical prostatectomy, and to understand the evolution.
Robotic surgery for rectal cancer: A systematic review of current practice

Tony Wing Chung Mak,Janet Fung Yee Lee,Kaori Futaba,Sophie Sok Fei Hon,Dennis Kwok Yu Ngo,Simon Siu Man Ng

DOI: https://doi.org/10.4251/wjgo.v6.i6.184

2014-01-01

World Journal of Gastrointestinal Oncology

Abstract:AIM: To give a comprehensive review of current literature on robotic rectal cancer surgery.METHODS: A systematic review of current literature via PubMed and Embase search engines was performed to identify relevant articles from january 2007 to november 2013. The keywords used were: "robotic surgery", "surgical robotics", "laparoscopic computer-assisted surgery", "colectomy" and "rectal resection".RESULTS: After the initial screen of 380 articles, 20 papers were selected for review. A total of 1062 patients (male 64.0%) with a mean age of 61.1 years and body mass index of 24.9 kg/m(2) were included in the review. Out of 1062 robotic-assisted operations, 831 (78.2%) anterior and low anterior resections, 132 (12.4%) intersphincteric resection with coloanal anastomosis, 98 (9.3%) abdominoperineal resections and 1 (0.1%) Hartmann's operation were included in the review. Robotic rectal surgery was associated with longer operative time but with comparable oncological results and anastomotic leak rate when compared with laparoscopic rectal surgery.CONCLUSION: Robotic colorectal surgery has continued to evolve to its current state with promising results; feasible surgical option with low conversion rate and comparable short-term oncological results. The challenges faced with robotic surgery are for more high quality studies to justify its cost.

oncology,gastroenterology & hepatology
Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery

Hideaki Miyake,Masato Fujisawa

DOI: https://doi.org/10.1007/s10147-024-02503-5

2024-04-18

International Journal of Clinical Oncology

Abstract:In the field of urology, robotic surgery has gained rapid and wide acceptance as a standard surgical approach in the majority of major surgeries over the last decade. To date, the da Vinci surgical system has been the dominant platform in robotic surgery; however, several newly developed robotic systems have recently been introduced in routine clinical practice. Of these, hinotori, the first made-in-Japan robotic system, is characterized by various unique and attractive features different from the existing system, and the use of this system has gradually increased mainly in urologic cancer surgeries, including radical prostatectomy, partial nephrectomy, radical nephrectomy, and radical nephroureterectomy. This review initially describes detailed characteristics of hinotori, then summarizes the early experience with urologic cancer surgeries using hinotori at our institution, and finally discusses the future prospects of robotic surgery using hinotori, considering problems associated with the use of this robotic system.

oncology
Impacts of completely endophytic renal masses on perioperative, oncologic, and functional outcomes in robot-assisted partial nephrectomy: a systematic review and meta-analysis

Han-xiao Gu,Jia Lv,Yi Liu

DOI: https://doi.org/10.3389/fonc.2024.1444477

IF: 4.7

2024-10-25

Frontiers in Oncology

Abstract:Background: The objective of this study was to perform a comprehensive pooled analysis aimed at comparing the efficacy and safety of robot-assisted partial nephrectomy (RAPN) between completely endophytic tumors (CERT) and non-completely endophytic tumors (non-CERT). Methods: This study adhered rigorously to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct a systematic review and meta-analysis. We performed a systematic search in the PubMed, Embase, Web of Science, and Cochrane Library databases, focusing on studies published in English up to May 2024. Our analysis primarily evaluated key outcomes, specifically perioperative, functional, and oncological outcomes. Results: A total of 2126 patients across six studies were included in the analysis. Compared to non-CERT, CERT was associated with significantly higher rates of major complications (Odds Ratio [OR]: 2.47; 95% CI: 1.14 to 5.34; p = 0.02), longer warm ischemia times (Weighted Mean Difference [WMD]: 3.27 min; 95% CI: 0.61 to 5.39; p = 0.02), a greater decline in estimated glomerular filtration rate (eGFR) (WMD: 2.93 ml/min/1.73 m 2 ; 95% CI: 0.75 to 5.11; p = 0.008), and relatively lower trifecta achievement rates (OR: 0.63; 95% CI: 0.41 to 0.96; p = 0.03). However, no statistically significant differences were observed between the two groups in terms of operative time, length of stay, blood loss, transfusion rates, intraoperative complications, overall complications, positive surgical margins, and local recurrence. Conclusions: Although CERT was associated with greater declines in eGFR and lower rates of trifecta achievement, it yielded perioperative, functional, and oncologic outcomes comparable to those of non-CERT in RAPN. Our findings suggest that RAPN for completely endophytic renal masses can achieve acceptable outcomes when performed in centers with substantial expertise in robotic surgery. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=555067, identifier CRD42024555067.

oncology
Recent Advances and Future Horizons in Robotic Radical Prostatectomy

Abrar H. Mian,Matthew K. Tollefson,Paras Shah,Vidit Sharma,Ahmed Mian,R. Houston Thompson,Stephen A. Boorjian,Igor Frank,Abhinav Khanna

DOI: https://doi.org/10.3390/jcm13020359

IF: 3.9

2024-01-10

Journal of Clinical Medicine

Abstract:Robotic-assisted radical prostatectomy (RARP) has become the leading approach for radical prostatectomy driven by innovations aimed at improving functional and oncological outcomes. The initial advancement in this field was transperitoneal multiport robotics, which has since undergone numerous technical modifications. These enhancements include the development of extraperitoneal, transperineal, and transvesical approaches to radical prostatectomy, greatly facilitated by the advent of the Single Port (SP) robot. This review offers a comprehensive analysis of these evolving techniques and their impact on RARP. Additionally, we explore the transformative role of artificial intelligence (AI) in digitizing robotic prostatectomy. AI advancements, particularly in automated surgical video analysis using computer vision technology, are unprecedented in their scope. These developments hold the potential to revolutionize surgeon feedback and assessment and transform surgical documentation, and they could lay the groundwork for real-time AI decision support during surgical procedures in the future. Furthermore, we discuss future robotic platforms and their potential to further enhance the field of RARP. Overall, the field of minimally invasive radical prostatectomy for prostate cancer has been an incubator of innovation over the last two decades. This review focuses on some recent developments in robotic prostatectomy, provides an overview of the next frontier in AI innovation during prostate cancer surgery, and highlights novel robotic platforms that may play an increasing role in prostate cancer surgery in the future.

medicine, general & internal

Current status of robot-assisted total pelvic exenteration focusing on the field of urology: a clinical practice review

Robotic versus open and laparoscopic pelvic exenterations for pelvic cancer: a multicenter propensity-matched analysis in Japan

Robotic Partial Nephrectomy: Current Technique and Outcomes

Current status and future perspective of robot‐assisted radical cystectomy for invasive bladder cancer

Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus after Robot-Assisted Laparoscopic Radical Cystectomy

Current Status of Robotics in Urologic Laparoscopy

Robotic-assisted laparoscopic surgery: recent advances in urology

Robot-assisted radical cystectomy for bladder cancer after low anterior resection: A case report

The current state and the future of robotic surgery in female pelvic medicine and reconstructive surgery.

Robot-Assisted Surgery for Endometriosis Current and Future Perspectives

AB099. Pelvic Exenteration for Primary and Recurrent Malignancies in Urology Department

A systematic review and meta-analysis on mortality rate following total pelvic exenteration in cancer patients

Minimally invasive pelvic exenteration for primary or recurrent locally advanced rectal cancer: A glimpse into the future

Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia

Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis

Robotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic review

Current status, evolution, and future perspectives in robotic platform systems for prostate cancer treatment: a narrative review

Robotic surgery for rectal cancer: A systematic review of current practice

Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery

Impacts of completely endophytic renal masses on perioperative, oncologic, and functional outcomes in robot-assisted partial nephrectomy: a systematic review and meta-analysis

Recent Advances and Future Horizons in Robotic Radical Prostatectomy